Thursday, 11 October 2018

Bristol-Myers to invest in Compugen, collaborate in clinical trials

Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumors.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)